Am J Transplant, Volume 20, Suppl 3 Archives - Page 195 of 223 - ATC Abstracts

2020 American Transplant Congress
Evaluation of Clinical Outcomes in Patients Receiving Antithrombotic Therapy Prior to Kidney Transplantation
A. Diamond¹, C. Antonacci², K. Lau³, A. Di Carlo³, S. Karhadkar³
¹Pharmacy, Temple University Hospital, Philadelphia, PA, ²Temple University School of Medicine, Philadelphia, PA, ³Surgery, Temple University Hospital, Philadelphia, PA
*Purpose: Patients with end stage renal disease (ESRD) often have significant cardiovascular comorbidities. Utilization of therapeutic anticoagulation (AC) and/or antiplatelet (AP) therapy poses an increased…
2020 American Transplant Congress
Transition from Youth to Adult Care of Kidney Transplant Recipients: Single Center Experience
L. Ganesan, A. McGrath, K. Dahl, K. Dinello, A. Fong, L. Maestretti, M. Patton, P. Grimm, A. Chaudhuri
Pediatric Nephrology, Lucile Packard Children's Hospital, Stanford, CA
*Purpose: Transition of transplant recipients from youth to adult care has been a challenge for many. Starting in March 2017, Lucile Packard Children’s Hospital (LPCH)…
2020 American Transplant Congress
Comparison of 4 vs 14 Days Early Steroid Withdrawal in Kidney Transplant Recipients
O. Adebiyi, J. Chen, B. Brady, S. Mietz, T. Taber, D. Mishler, M. Yaqub, W. Goggins, A. Sharfuddin
Indiana University, Indianapolis, IN
*Purpose: The optimal duration, as well as the dose of the initial steroid use, is not known as it varies widely among institutions that have…
2020 American Transplant Congress
MTOR Inhibitor Management and Wound Complications in Liver Transplant Recipients Undergoing Subsequent Surgeries
K. Neuhaus, B. Eghtesad, K. Hashimoto, M. Spinner, J. Bollinger, J. Eckardt
Cleveland Clinic, Cleveland, OH
*Purpose: Class-related, concentration-dependent adverse effects associated with mTOR inhibitors (mTORi) include wound complications such as impaired wound healing, incisional hernias, hepatic artery thrombosis, and lymphocele…
2020 American Transplant Congress
Reducing Travel While Improving Geographic Equity: Continuous Distribution with “Gravity Functions”
M. Mankowski¹, N. Wood², S. Gentry², D. Segev³
¹King Abdullah University of Science and Technology, Thuwal, Saudi Arabia, ²US Naval Academy, Annapolis, MD, ³Johns Hopkins University, Baltimore, MD
*Purpose: Recently, the OPTN board selected the continuous distribution framework for future organ allocation changes. Continuous distribution allocates organs without geographic boundaries, for example, by…
2020 American Transplant Congress
Long Term Ursodeoxycholic Acid Use Does Not Alter Long Term Rejection, Biliary Complication, Mortality or Hospitalization Rates after Liver Transplantation
T. Ashraf¹, V. Mendiratta², S. Gill¹, A. Abdelwahab³, D. Moonka², S. Jafri²
¹Internal Medicine, Henry Ford Hospital, Detroit, MI, ²Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI, ³Wayne State University, Detroit, MI
*Purpose: Endogenous bile acids are suspected to contribute to hepatobiliary injury after liver transplantation through direct cytotoxic effects. Ursodeoxycholic acid (UDCA) has been shown to…
2020 American Transplant Congress
Imaging Features and Diagnostic Accuracy of MRI in Combined Hepatocholangiocarcinoma
M. Najjar¹, J. Makkar¹, S. Sun¹, J. Zou¹, O. Perez¹, P. Jiang¹, Y. Saenger¹, E. Zheng¹, E. Verna¹, A. Mathur¹, A. Griesemer¹, K. Halazun², B. Samstein², T. Kato¹, J. Emond¹
¹Columbia University Medical Center/New-York Presbyterian, New York, NY, ²Weill Cornell Medicine, New York, NY
*Purpose: Combined hepatocholangiocarcinomas (HCC-CCA) are rare tumors with both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) differentiations. They are usually associated with a worse prognosis after…
2020 American Transplant Congress
Non-Linear Relationship between Recipient BMI and Survival Outcomes after Liver Transplantation-A Dose-Response Meta-Analysis
T. Song
Organ Transplantation Center, Urology Department, Urology Research Institute, West China Hospital, Sichuan University, Chengdu City, China
*Purpose: Dose-response relationship between preoperative and postoperative body mass index (BMI) and survival outcomes after liver transplantation (LT) has not been clearly defined yet.*Methods: PubMed,…
2020 American Transplant Congress
Evaluation of a Surveillance after Prophylaxis Strategy for Cytomegalovirus Prevention in Liver Transplant Recipients
N. Parrish¹, A. Webb², T. Kaiser¹, S. Shah¹, N. Anwar¹, K. Luckett¹
¹University of Cincinnati Med Ctr, Cincinnati, OH, ²Tampa General Hospital, Tampa, FL
*Purpose: Despite prophylaxis and preemptive strategies, CMV infection remains a common complication post liver transplant (LT). CMV surveillance after prophylaxis may improve outcomes, but supporting…
2020 American Transplant Congress
The Value of Pharmacist-Driven Valganciclovir Dosing in Kidney Transplant Recipients in Reducing CMV Infection: A Single Center Experience
K. D. Belfield¹, C. E. Costello², M. Malinis³
¹Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, ²University of Connecticut School of Pharmacy, Storrs, CT, ³Section of Infectious Diseases,, Yale School of Medicine, New Haven, CT
*Purpose: Cytomegalovirus (CMV) is a common viral infection after kidney transplant (KT) despite prophylaxis with valganciclovir (VGCV). VGCV is renally dosed and can be a…